Adma Biologics, Inc.
ADMA· Nasdaq
Released Nov 10, 2014, before the open
10-Q filed Nov 10, 2014, 41 days after period end · 0001193805-14-002117
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Revenue | $1.37M | $1.11M | $360.34K | $0.00 |
| Net Income | -$3.38M | -$2.69M | -$3.25M | -$981.08K |
| EPS Diluted | -$0.36 |
Adma Biologics, Inc. · CIK 1368514 · Engraved from SEC EDGAR
| -$0.46 |
| -$0.55 |
| -$2.79 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.